Skip to main content

Leslie K. Ferrarelli

Leslie K. Ferrarelli

Science Signaling, AAAS, Washington, DC 20005, USA

Twitter

Latest Stories

A target for medulloblastoma

By Leslie K. FerrarelliSep. 14, 2018
Synthetic lethality with cisplatin

By Leslie K. FerrarelliAug. 21, 2018
Modeling chemotherapy-drug combinations

By Stella Hurtley, Leslie K. FerrarelliJul. 27, 2018
An alternative treatment for leukemia

By Stella Hurtley, Leslie K. FerrarelliJul. 20, 2018
CRISPR, cancer, and p53

By Leslie K. FerrarelliJul. 17, 2018
Inflammatory decoy control

By Caroline Ash, Leslie K. FerrarelliJun. 29, 2018
Dialing down the opioids

By Caroline Ash, Leslie K. FerrarelliJun. 22, 2018
New connections: Engineering DNA repair vulnerability to treat cancer

By Leslie K. FerrarelliJun. 19, 2018
DNA-bound ubiquitin coordinates repair

By Stella Hurtley, Leslie K. FerrarelliJun. 8, 2018
Fat, microRNAs, and liver disease

By Caroline Ash, Leslie K. FerrarelliMay. 18, 2018
New connections: Kinases and phosphatases in control of mitosis

By Leslie K. FerrarelliMay. 15, 2018
New connections: Ewing’s sarcoma’s driver is its Achilles’ heel

By Leslie K. FerrarelliApr. 24, 2018
Pinpointing amyloid's toxicity

By Stella Hurtley, Leslie K. FerrarelliMar. 23, 2018
New connections: Amyloid-β in the pathology of Alzheimer’s disease

By Leslie K. FerrarelliMar. 20, 2018
Epigenetic ignition of melanoma

By Leslie K. FerrarelliMar. 13, 2018
Kinase networks in inflammation

By Stella Hurtley, Leslie K. FerrarelliMar. 9, 2018

Latest News

Staff Writers